We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis, Mylan Spar Over Breast Cancer Treatment

Law360 (June 28, 2006, 12:00 AM EDT) -- Drug makers Novartis Pharmaceuticals and Mylan Pharmaceuticals will meet in court over the patents for breast cancer treatment Femara, after an Abbreviated New Drug Application prompted Novartis to slap the generics...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.